Professur für Molekulare Mechanismen der Organfibrose

INFLUENCE OF B-CATENIN ON THE PROLIFERATION OF VASCULAR SMOOTH MUSCLE CELLS AND THE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY IN MICE (2020) Heim C, Kuckhahn A, Ramsperger-Gleixner M, Distler J, Spriewald BM, Weyand M, Ensminger SM Conference contribution Long noncoding RNA H19X is a key mediator of TGF-β-driven fibrosis (2020) Pachera E, Assassi S, Salazar GA, Stellato M, Renoux F, Wunderlin A, Blyszczuk P, et al. Journal article PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis (2020) Zhang Y, Shen L, Zhu H, Dreissigacker K, Distler D, Zhou X, Györfi AH, et al. Journal article Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study (2020) Jaeger VK, Tikly M, Xu D, Siegert E, Hachulla E, Airo P, Valentini G, et al. Journal article The AP1 Transcription Factor Fosl2 Promotes Systemic Autoimmunity and Inflammation by Repressing Treg Development (2020) Renoux F, Stellato M, Haftmann C, Vogetseder A, Huang R, Subramaniam A, Becker MO, et al. Journal article NINTEDANIB DOSE ADJUSTMENTS AND ADVERSE EVENTS IN PATIENTS WITH PROGRESSIVE AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES IN THE INBUILD TRIAL (2020) Volkmann E, Castellvi I, Johnson S, Matteson E, Distler J, Seibold J, Costabel U, et al. Conference contribution EFFECT OF NINTEDANIB ON PROGRESSION OF INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED ILDS: FURTHER DATA FROM THE INBUILD TRIAL (2020) Matteson E, Kelly C, Distler J, Hoffmann-Vold AM, Seibold J, Mittoo S, Distler O, et al. Conference contribution VASCULARIZED THREE-DIMENSIONAL MODELS OF HUMAN SKIN FIBROSIS (2020) Matei AE, Chen CW, Kiesewetter L, Györfi AH, Li YN, Trinh-Minh T, Van Kuppevelt T, et al. Conference contribution REAL-WORLD EFFECTIVENESS AND PERCEIVED USEFULNESS OF SYMPTOM CHECKERS IN RHEUMATOLOGY: INTERIM REPORT FROM THE PROSPECTIVE MULTICENTER BETTER STUDY (2020) Knitza J, Mohn J, Bergmann C, Kampylafka E, Hagen M, Bohr D, Araujo E, et al. Conference contribution FIBROBLAST GROWTH FACTOR RECEPTOR 3 REGULATES THE ACTIVITY OF PROFIBROTIC CYTOKINE AND GROWTH FACTOR PATHWAYS TO DRIVE FIBROBLAST ACTIVATION AND TISSUE FIBROSIS IN SYSTEMIC SCLEROSIS (2020) Chakraborty D, Zhu H, Juengel A, Summa L, Li YN, Bergmann C, Matei AE, et al. Conference contribution